Why the study?
Underlying inflammation may often be unrecognized in patients with premature ventricular contractions, leading to potential disease progression if not diagnosed and treated early.
Does a diagnostic strategy including 18F-FDG PET identify underlying myocarditis and guide effective immunosuppressive therapy in patients with frequent symptomatic premature ventricular contractions?
Does a diagnostic strategy including 18F-FDG PET identify underlying myocarditis and guide effective immunosuppressive therapy in patients with frequent symptomatic premature ventricular contractions?
Approximately half of patients with frequent PVCs and no ischemic heart disease have underlying myocardial inflammation, and targeted immunosuppressive therapy can improve clinical outcomes and LVEF.
Screening for occult myocarditis may be considered in frequent symptomatic PVCs; leaves open whether immunosuppression alters progression or outcomes.
BACKGROUND: Premature ventricular contractions are a common clinical presentation that drives further diagnostic workup. We hypothesize the presence of underlying inflammation is often unrecognized in these patients with a potential for continued disease progression if not diagnosed and treated early in the disease course. METHODS: This is a single-center, prospective study including 107 patients with frequent symptomatic premature ventricular contractions (>5000/24 h) and no known ischemic heart disease. Patients underwent a combination of laboratory testing, 18F-fluorodeoxyglucose positron emission tomography scan, cardiac magnetic resonance imaging, and biopsy. Patients were diagnosed with myocarditis based on a multidisciplinary approach and treated with immunosuppressive therapy. RESULTS: The mean age of the cohort was 57±15 years, 41% were males, and left ventricular ejection fraction was 47±11.8%. Positive positron emission tomography scan was seen in 51% (55/107), of which 51% (28/55) had preserved left ventricle function. Based on clinical profile, 18F-fluorodeoxyglucose-positron emission tomography imaging, cardiac magnetic resonance, and histological data 58% patients (32/55) received immunosuppressive therapy alone and 25.4% (14/55) received immunosuppressive therapy and catheter ablation. Optimal response was seen in 67% (31/46) over a mean follow-up of 6±3 months. In patients with left ventricle systolic dysfunction, 37% (10/27) showed an improvement in mean left ventricular ejection fraction of 13±6%. CONCLUSIONS: Approximately 51% of patients presenting with frequent premature ventricular contractions have underlying myocardial inflammation in this cohort. 18F-fluorodeoxyglucose-positron emission tomography scan can be a useful modality for early diagnosis and treatment with immunosuppressive therapy in selected patients can improve clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Lakkireddy et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: